BackReneo Pharmaceuticals Overview

Reneo Pharmaceuticals Total Assets

Latest total assets for RPHM: $200M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$198.69M
98.93% YoYΔ $98.81M vs prior year quarter

Peer average

Loading

Reneo Pharmaceuticals Total Assets History

Loading

Reneo Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Reneo Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Reneo Pharmaceuticals (RPHM) FAQ

As of the most recent data (March 2026), RPHM shows a total assets of $200M. That compares with $100M in the prior-year period — up 98.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RPHM's total assets is now $200M (was $100M) — a 98.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Reneo Pharmaceuticals is outperforming or lagging.

Tracking RPHM's total assets over time shows whether Reneo Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $100M in the prior-year period — up 98.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Reneo Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $200M) with ownership activity and broader fundamentals.

Reneo Pharmaceuticals's total assets is $200M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.